Skip to main content
CRMD
NASDAQ Life Sciences

CorMedix Backs FY26 Revenue Guidance of $325M-$345M

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.65
Mkt Cap
$557.008M
52W Low
$6.125
52W High
$14.96
52W Position info
25% above low
Off High info
49% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

CRMD sits 25% above its 52-week low of $6.125.

Summary

CorMedix reaffirmed its fiscal 2026 revenue guidance of $325M-$345M, following Q2 revenue of $101.9M (up 157% YoY). The company narrowed its FY cash operating expense guidance to $145M-$155M and raised its FY adjusted EBITDA guidance to $125M-$140M. The revenue guidance implies a significant ramp in the second half, driven by MINOCIN for Injection and DefenCath. This follows a patent litigation win in June and a derivative lawsuit settlement last week. The reaffirmation removes uncertainty around the full-year outlook and supports the current valuation.

At the time of this announcement, CRMD was trading at $7.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $557M. The 52-week trading range was $6.13 to $14.96. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CRMD - Latest Insights

CRMD
Nov 16, 2026, 7:30 AM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $4.61
Real-time Price: $4.59 info
Change: -$0.020 (-0.43%) info
Market Cap: $404.051M info
CRMD
Nov 12, 2026, 8:21 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.15
Real-time Price: $4.59 info
Change: -$0.560 (-11%) info
Market Cap: $404.051M info
CRMD
Nov 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $4.59 info
Change: -$0.660 (-13%) info
Market Cap: $404.051M info
CRMD
Nov 12, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $4.59 info
Change: -$0.660 (-13%) info
Market Cap: $404.051M info
CRMD
Nov 09, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $5.50
Real-time Price: $4.59 info
Change: -$0.910 (-17%) info
Market Cap: $404.051M info